Journal History
| 2003 | Marine Drugs was founded at the Ocean University of China. The inaugural issue was released. Marine Drugs was published as a quarterly journal. |
| 2005 | Marine Drugs was indexed in Science Citation Index Expanded (SCIE)—Web of Science (Clarivate Analytics), starting with Volume 3 (Issue 1). |
| 2007 | Marine Drugs was indexed in PubMed. |
| 2010 | Marine Drugs adopted a monthly publication schedule. Marine Drugs was indexed in Scopus (Elsevier), starting with Volume 5 (Issue 1). The Impact Factor increased to 3.471. |
| 2012 | The Impact Factor increased to 3.854. |
| 2013 | Marine Drugs received its 2012 Impact Factor (3.978), ranked 6/59 in “Medicinal Chemistry”. Marine Drugs launched its Best Paper Award. |
| 2014 | Marine Drugs received its 2013 Impact Factor (3.512), ranked 10/58 in “Medicinal Chemistry”. |
| 2015 | Marine Drugs received its 2014 Impact Factor (2.853), ranked 22/59 in “Medicinal Chemistry”. Marine Drugs created its Twitter account. |
| 2016 | Marine Drugs received its 2015 Impact Factor (3.345), ranked 13/59 in “Medicinal Chemistry”. Marine Drugs announced the first edition of the Young Investigator Award. |
| 2017 | Marine Drugs received its 2016 Impact Factor (3.503), ranked 13/60 in “Medicinal Chemistry”. |
| 2018 | Marine Drugs received its 2017 Impact Factor (4.379), ranked 5/59 in “Medicinal Chemistry”. |
| 2019 | Marine Drugs received its 2018 Impact Factor (3.772), ranked 15/61 (Q1) in “Medicinal Chemistry”. |
| 2020 | The Impact Factor increased to 4.073. Marine Drugs received its CiteScore (2019) of 5.1. The Australia New Zealand Marine Biotechnology Society (ANZMBS) became affiliated to Marine Drugs. |
| 2021 | Marine Drugs received its 2020 Impact Factor (5.118), ranked 12/62 (Q1) in “Medicinal Chemistry”, and ranked 60/276 (Q1) in "Pharmacology & Pharmacy". Marine Drugs received its CiteScore (2020) of 6.4, ranked 86% in “Pharmacology, Toxicology and Pharmaceutics (miscellaneous)”, ranked 83% in “Pharmaceutical Science”, ranked 78% in “Drug Discovery”. |
| 2022 | Marine Drugs received its 2021 Impact Factor (6.085), ranked 10/63 (Q1) in “Chemistry, Medicinal”, ranked 48/279 (Q1) in “Pharmacology & Pharmacy”. Marine Drugs received its CiteScore (2021) of 8.1, ranked 88% in Category “Pharmacology, Toxicology and Pharmaceutics (miscellaneous)”, ranked 86% in “Pharmaceutical Science”, ranked 82% in “Drug Discovery”. Marine Drugs established the following sections:
|
| 2023 | The year 2023 marked the 20th Anniversary of Marine Drugs. Marine Drugs received its 2022 Impact Factor (5.4), ranked 13/60 (Q1) in JCR Category “Chemistry, Medicinal” and 51/277 (Q1) in JCR Category “Pharmacology, Pharmacy”. Marine Drugs received its CiteScore (2022) of 9.6, ranked 92% in Category “Pharmacology, Toxicology and Pharmaceutics (miscellaneous)”, ranked 86% in “Pharmaceutical Science”, ranked 84% in “Drug Discovery”. |
| 2024 |
Marine Drugs received its 2023 Impact Factor (4.9), ranked 13/72 (Q1) in JCR Category “Chemistry, Medicinal” and 45/354 (Q1) in JCR Category “Pharmacology, Pharmacy”. |
Editor-in-Chief
| 2003–2005 | Editor-in-Chief: Prof. Dr. Hua-Shi Guan |
| 2005–2009 | Editor-in-Chief: Prof. Dr. Peter Proksch |
| 2009–2013 | Editor-in-Chief: Prof. Dr. Hartmut Laatsch |
| 2014–2018 | Editor-in-Chief: Prof. Dr. Alejandro M. Mayer |
| 2018–2022 | Editor-in-Chief: Prof. Dr. Orazio Taglialatela-Scafati |
| 2022–present | Editor-in-Chief: Prof. Dr. Bill J. Baker |
Section Editor-in-Chief
| 2022 | Section Editor-in-Cheif: Prof. Dr. Bill J. Baker for the Section on Marine Toxins |
| 2022–present | Section Editor-in-Cheif: Prof. Dr. Anake Kijjoa for the Section on Structural Studies on Marine Natural Products Section Editor-in-Cheif: Prof. Dr. Vassilios Roussis for the Section on Marine Chemoecology for Drug Discovery Section Editor-in-Cheif: Prof. Dr. Marialuisa Menna for the Section on Synthesis and Medicinal Chemistry of Marine Natural Products Section Editor-in-Cheif: Prof. Dr. Marc Diederich for the Section on Marine Pharmacology Section Editor-in-Cheif: Prof. Dr. Hermann Ehrlich for the Section on Biomaterials of Marine Origin Section Editor-in-Cheif: Prof. Dr. Yue-Wei Guo for the Section on Marine-Derived Ingredients for Drugs, Cosmeceuticals and Nutraceuticals Section Editor-in-Cheif: Dr. Ipek Kurtboke for the Section on Marine Biotechnology Related to Drug Discovery or Production Section Editor-in-Cheif: Dr. Andrew Turner for the Section on Marine Toxins |
